For UK healthcare professionals only

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

This webinar is broadcast in association with the British Journal of Cardiology; our media partner is GPnotebook, who have had no input into the content of the activity.

ESC Congress 2024 highlights - A UK perspective

On demand

What’s new in the latest ESC guideline update?

Presenters:

Dr Paul Foley

Prof Terry McCormack

A review of the most significant changes in the 2024 guideline updates, and what they mean for everyday UK practice:

  • Elevated blood pressure and hypertension
  • Chronic coronary syndromes
  • Atrial fibrillation
  • Peripheral arterial and aortic disease

This site is intended for UK healthcare professionals only

To continue, please confirm that you are a UK healthcare professional.